Clinical Trials Browser

Phase 1 × Neoplasms × Bendamustine Hydrochloride × Clear all

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Mycosis Fungoides, Neoplasms, Sezary Syndrome, Lymphoma, T-Cell, Cutaneous, Lymphomatoid Papulosis

NCT01594229 2021-08-02

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Phase 1 Completed

60 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms

NCT01691807 2018-02-28

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

Phase 1 Completed

30 enrolled

Lymphoid

Lymphoma, Non-Hodgkin, Neoplasms

NCT00863850 2012-04-23

Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy

Phase 1 Completed

6 enrolled

Tumor-Agnostic

Neoplasms

Clinical Trials

Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL

A Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Combination With Bendamustine/Rituximab (BR) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma

Drug-drug Interaction Study of Ofatumumab With Bendamustine in Subjects With Indolent B-cell Non-Hodgkin's Lymphoma

Pharmacokinetics of Bendamustine Hydrochloride in Patients With Relapsed or Refractory Malignancy